In the latest quarter, 4 analysts provided ratings for Sangamo Therapeutics (NASDAQ:SGMO), showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 0 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 2 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $3.0, a high estimate of $3.00, and a low estimate of $3.00. The current average, unchanged from the previous average price target, holds steady.
Breaking Down Analyst Ratings: A Detailed Examination
The standing of Sangamo Therapeutics among financial experts is revealed through an in-depth...
Login or create a forever free account to read this news
Sign up/Log in